Adhesion of multiple myeloma (MM) cells t o bone marrow stromal cells (BMSCsl not only localizes MM cells in the marrow microenvironment, but also triggers interleukin-6 (IL-6) secretion by BMSCs and related MM cell proliferation. In the present study, we characterized the regulation of IL-6 gene expression in BMSCs during MM cell adhesion. Adhesion of ARH-77, HS-Sultan, IM-9, and U266 MM cell lines t o BMSCs and BMSC lines (LP 101 and AA 101) triggered 5-through 15-fold and 2-through 4-fold increases in IL-6 secretion, respectively. IL-6 mRNA transcripts were undetectable by Northern blotting in IM-9 MM cells or LP 101 BMSCs cultured alone; however, adherence of IM-9 cells t o LP 101 cells induced a transient increase in IL-6 transcripts at 6 hours, followed by peak IL-6 secretion at 24 hours. To confirm increased IL-6 transcription and characterize its regulation, LPlOl BMSCs were transiently transfected with full length and deletion fragments of the IL-6 promoter linked t o the chloramphenicol acetyltransferase (CAT) reporter gene. taining an intact NF-KB site showed a 6.8 ? 0.4-fold increase in CAT activity triggered by IM-9 MM cell adhesion (n = 3, P < .05). Transfection of LP 101 cells with plasmid containing a single base pair deletion from the NF-KB binding motif abolished the MM adhesion-induced increase in CAT activity, whereas transfection with plasmid containing three copies of synthetic NF-KB sequence resulted in an 8.1 f 0.7-fold increase in CAT activity related t o MM adhesion (n = 3, P < .05). These data suggest that the NF-KB site is one of the essential regulatory elements for MM cell adhesion-induced IL-6 transcription in BMSCs. Electrophoretic mobility shift assays confirmed the involvement of NF-KB activation in regulating MM adhesion-induced IL-6 transcription in BMSCs. Further characterization of the upstream events in the signalling cascade regulating IL-6 may not only delineate mechanisms of IL-6 regulation during paracrine MM cell growth, but also provide new therapeutic strategies based on interruption of IL-6 mediated tumor cell growth.
Adhesion of multiple myeloma (MM) cells t o bone marrow stromal cells (BMSCsl not only localizes MM cells in the marrow microenvironment, but also triggers interleukin-6 (IL-6) secretion by BMSCs and related MM cell proliferation. In the present study, we characterized the regulation of IL-6 gene expression in BMSCs during MM cell adhesion. Adhesion of ARH-77, HS-Sultan, IM-9, and U266 MM cell lines t o BMSCs and BMSC lines (LP 101 and AA 101) triggered 5-through 15-fold and 2-through 4-fold increases in IL-6 secretion, respectively. IL-6 mRNA transcripts were undetectable by Northern blotting in IM-9 MM cells or LP 101 BMSCs cultured alone; however, adherence of IM-9 cells t o LP 101 cells induced a transient increase in IL-6 transcripts at 6 hours, followed by peak IL-6 secretion at 24 hours. To confirm increased IL-6 transcription and characterize its regulation, LPlOl BMSCs were transiently transfected with full length and deletion fragments of the IL-6 promoter linked t o the chloramphenicol acetyltransferase (CAT) reporter gene. Transient transfection of LPlOl BMSCs with plasmid con-E HAVE used B-cell antigens and immunofluorescence techniques to characterize secretory B-cell malignancies and to define the role of recombinant B-cell growth factors in their g r 0~t h . I .~ Interleukin-4 (IL-4) has been noted to inhibit the in vitro growth of tumor samples from patients with multiple myeloma
In contrast, IL-6 is proposed to be either an autocrine or paracrine growth factor for MM.".h.10"4 Specifically, Kawano et alls postulate an autocrine growth mechanism because ( I ) IL-6 induces in vitro growth of freshly isolated MM cells; (2) MM cells express the IL-6 receptor (IL-6R); (3) purified MM cells produce IL-6; and (4) in vitro growth of MM cells is inhibited by anti-IL-6 antibody. In support of an autocrine theory, Freeman et all6 have shown that MM and plasma cell leukemia cells express IL-6 mRNA. Hata et all7 found that tumor cells from 45% of patients expressed IL-6 mRNA; IL-6R transcripts were found in 68% of tumor specimens, also consistent with an autocrine growth mechanism in some patients. In addition, some cell line data supports this view:
in particular, MM cell lines have been described that are responsive to and produce IL-6; their growth can be inhibited by an antibody to IL-6 and/or IL-6 antisense oligonucleotides.lX-22 Most recently, an IL-6 dependent human MMderived cell line as well as freshly isolated MM cells have been triggered via their cell surface CD 40 to both secrete IL-6 and to proliferate, suggesting the potential for induction of IL-6-mediated autocrine growth in Despite the above studies, an IL-6-mediated autocrine growth mechanism in MM remains controversial, because many studies have shown that bone marrow stromal cells (BMSCs) are the major source of IL-6.".12,'4 Furthermore, although all human MM-derived cell lines express IL-6R mRNA, only a subset express IL-6 mRNA. Our studies have shown that freshly isolated MM cells or MM-derived cell lines express functional IL-6Rs and proliferate in response to exogenous IL-6; however, only a fraction of cells also synthesize IL-6, compatible with an autocrine growth pattern.'.' Multiple groups have shown that MM cells express cell surface adhesion molecules, ie, CD29KDw49d (VLA-4), VLA-5, CDl8KDlla (LFA-l), CD44, CD 21, MPC-I, syndecan, which localize MM cells in marrow via specific adherence to both marrow extracellular matrix proteins and to BMSCS.'~"~ Most importantly, MM cell adhesion triggers IL-6 secretion by normal or MM BMSCs and related IL-6-mediated tumor cell This process requires cell to cell contact between tumor and BMSCs. Moreover, paraformaldehyde fixation of the BMSCs before tumor cell adhesion abrogates IL-6 secretion, suggesting that BMSCs are the major source of IL-6-mediating paracrine tumor cell growth." To date, however, the mechanism whereby tumor cell adhesion induced IL-6 expression in BMSCs is regulated remains undefined.
In the present report, we studied the molecular mechanism involved in the transcriptional activation of IL-6 gene in BMSCs triggered by MM cell adhesion. Adhesion of MM cell lines to BMSCs and BMSC lines resulted in significant BMSCs triggered a transient increase in IL-6 transcripts that preceded maximal IL-6 secretion. Full-length or deletion fragments of the IL-6 promoter linked to the chloramphenicol acetyltransferase (CAT) reporter gene were transfected into BMSCs before MM cell adhesion: these experiments indicated involvement of the NF-KB binding site in the induction of IL-6 gene transcription. Finally, electrophoretic mobility shift assays (EMSAs) showed increased NF-KB binding activity in BMSCs after MM cell adhesion, and antibodies against members of the reVNF-KB family revealed the presence of p50, c-rel, and smaller quantities of p65 in the complex induced by IM-9 MM cell adherence to LPlOl BMSCs. These studies confirm a role for NF-KB activation in regulation of IL-6 transcription triggered in BMSCs after MM cell adhesion.
MATERIALS AND METHODS
Cells and cell culrure. The IM-9, ARH-77, HS Sultan, and U-266 human MM-derived cell lines6 were obtained from American Type Culture Collection (Rockville, MD). Cells were cultured in RPMI-1640 containing 10% to 15% fetal bovine serum (FBS), 100 U/mL penicillin (pen), and 100 mg/mL streptomycin (strep) (GIBCO, Grand Island, NY). The normal human BMSC lines LP101 and AAlOl were kindly provided by Dr Shin Aizawa (Tokyo Medical College) and cultured in Iscove's Modified Dulbecco Medium (IMDM), containing 10% FBS, and pen/strep. Assays of adhesion of MM cell lines to BMSCs were done as previously described.'".'" Briefly, BMSCs were cultured (1 X lo5 cells/mL) for 24 hours to obtain a confluent monolayer. After BMSCs formed a confluent adherent layer, remaining nonadherent cells were washed three times with Hanks' Buffered Saline Solution. Myeloma cells (5 X lo5 cell/ mL) were then added directly to BMSCs. After incubation at 37°C for 24 hours, the supernatants were collected, and remaining bound cells were procured for either Northern blot analysis or CAT assays.
Measurernenr of IL-6 secretion. IL-6 levels in the supernatants of BMSCs cultured in media or with adherent MM cell lines were measured in a bioassay using the B9 IL-6 dependent hybridoma cells, as previously described.' Test samples were heat-inactivated (56°C for 30 minutes) and sterile filtered before use. Triplicate test samples were serially diluted in 96-well microtitre plates (100 pW well) and 100 pL of B9 cells (5 X IO' cellslwell) suspended in IMDM containing 5% FBS, 5 X mercaptoethanol, and pen/ strep. Dilutions of recombinant IL-6 were included as a standard. B9 cells were then cultured for 72 hours, with the addition of tritiated thymidine (7.4 kBq/well) for the last 4 hours of culture. Thymidine uptake by the B9 cells was determined as described7; the lower limit of detection of IL-6 was 0.5 pg/mL. IL-6 was also measured using an enzyme-linked immunosorbent assay (ELISA; Endogen, Cambridge, MA), as previously described.'6 Serial dilutions (100 pL) of test sample supernatants were added in duplicate to 96 well plates (Costar, Cambridge, MA) coated with IgGl anti-IL-6 antibody (murine IgGI; TORAY, Kanagawa, Japan). Biotinylated detector anti-IL-6 monoclonal antibody (MoAb) (TORAY) was next added and developed with streptavidin (Amersham, Arlington Heights, IL). IL-6 level in each supernatant was determined by comparison with a standard curve. The level of detection of IL-6 was 1 ng/mL.
Measurement of IL-I and IL-8 secretion. The IL-I and IL-8 levels in culture supernatants were measured using ELISA kits (Endogen). The minimal detection limits were 50 pg/mL and 1 pg/mL for IL-I and IL-8, respectively.
RNA isolarion and Norrhern blotring. Total cellular RNA was isolated by a modification of the guanidine-isothiocyanate technique, as previously described.'6 Total cellular RNA (20 pg/lane) was subjected to electrophoresis in a 1% agarose12.2 mom formaldehyde gel, transferred to nitrocellulose paper, and hybridized to one of the following '*P-labeled DNA probes: (l) the pAl plasmid containing a 2.0-kb Psr I insert of the chicken &actin gene'7; and (2) the BanIITaq I fragment containing nucleotides 215 to 657 of a full-length human IL-6 cDNA.' The hybridizations were performed for 16 to 24 hours at 42°C in 50% (voUvol) formamide, 2 X SSC (SSC: 0.15 moVL sodium chloride, 0.015 mol/L sodium citrate), 1 X Denhardt's solution, 0.1% (wthol) sodium dodecyl sulfate, and 200 pg/mL salmon sperm DNA. Filters were washed and exposed to Kodak X-Omat XAR film (Eastman Kodak, Rochester, NY) using an intensifying screen. The autoradiograms were scanned using an LKB produkter (Bromma, Sweden) Ultrascan XL laser densitometer and analysed with the Gelscan XL software package (LKB). Signal intensity was determined in a linear range and normalized to that for actin.
CAT assays. The various IL-6 CAT constructs were prepared as previously described.'x Briefly, the parental BAMHIIXhoI fragment of IL-6 promoter was subjected to restriction enzyme digestion with Mva I (-630) and Hho I (-225). 5' deletional constructs were prepared from the pIL-6 CAT 225. The 5' deletions were constructed by BAL 31 resection of pIL-6 CAT 225 from the Xba I site and addition of BAMHI linkers. The resulting IL-6 BarnH1-Xho I fragments were ligated to pIL-6 CAT 3 digested with BarnHI and Xho I to generate 5' deletions (see Fig 3) . For cloning, complementary oligonucleotides were treated with kinase, annealed, and inserted at the BamHI site of the plasmid pIL-6 CAT 59, creating pIL-6 CAT The indicated plasmids (30 kg) (see Fig 3) were transfected into LP101 or AA101 BMSCs using electroporation, as previously described.'" Briefly, l .5 X IO7 BMSCs were procured and washed with phosphate-buffered saline. The cells were resuspended in 800 pL of media without serum, and incubated on ice for 10 minutes. The cells were pulsed with 240 V, 960 mF (Biorad Gene Pulser, Richmond, CA) using the standard vendor's protocol; incubated further on ice for 10 minutes; resuspended in complete media; and then incubated at 37°C. Twenty-four hours after transfection, IM-9 MM cells were added directly to the transfected confluent LPlOl or AAlOl BMSCs. The transfected BMSCs were also cultured alone as a control. After 24 hours, either BMSCs alone or BMSCs and IM-9 MM cells were procured and lysed by three cycles of freezing and thawing in 0.25 m o m Tris-HC1 (pH 7.8) and 1 mmol/L phenylmethylsulfonyl fluoride. To assay for CAT activity, equal amounts of the cell extracts were incubated with 0.025 pCi [I4C] chloramphenicol (Amersham; 57 uCi/mmol), 0.15 m o m Tris-HC1 (pH 7.8), and 0.4 mmol/L acetyl-coA (Sigma, St Louis, MO) for 4 hours at 37°C. The enzyme assay was terminated by the addition of ethyl acetate. The organic layer containing the acetylated [I4C] chloramphenicol was separated by thin layer chromatography using chlorofonmnethanol (95%/5%; voUvol). Following autoradiography, both acetylated and unacetylated forms of ['JC]chloramphenicol were cut from the plates, and the conversion of chloramphenicol to the acetylated form was calculated by measurement of radioactivity in a p-scintillation counter, as previously described."
The IM-9 MM cells were also transiently transfected with pIL-6CAT 630 and pIL-6CAT ~~/ N F -K B X 3 constructs. After 24 hours of culture, the transfected IM-9 MM cells were adhered to LP101 BMSCs, and the extracts analysed for CAT activity.
Cotransfections were also performed with a luciferase gene reporter construct (pGL2) as an internal control plasmid, as in previous
For personal use only. on October 23, 2017. by guest www.bloodjournal.org From studies.'y In particular, the CAT assays were performed with equal amounts of luciferase activity to normalize for any variation in transfection efficiency. Luciferase enzymatic activity was measured using "luciferin" as a substrate in the 'Luciferase Assay System,' per manufacturer's directions (Promega, Madison, WI). Luminescence was measured with a luminometer (Model TD-20e luminometer; Turner, Sunnyvale, CA). The results showed similar transfection efficiencies for all pIL-6 constructs shown (see Fig 3) .
Nuclear extracts and EMSAs. LP101 BMSCs were incubated in the presence or absence of IM9 MM cells for 1 hour, and nuclear extracts were prepared according to Dignam et In supershift assays, nuclear extracts were preincubated for 10 minutes in the presence of specific antiserum (anti-Re1 B, anti-c Rel, anti-p65, anti-p50 and anti-p52) (Santa Cruz Biotechnology, Santa Cruz, CA), before addition of probe and incubation for 15 minutes at room temperature.
RESULTS

Adhesion c$ IM-9 M M cells to LP101
BMSCs triggers IL-6 secretion. In the present study, four MM cell lines (ARH-77, IM-9, HS-Sultan [HSS] and U266), as well as the myelomonocytic leukemia cell line U937 were adhered to normal BMSCs. As in prior studies,"' MM cells showed 40% to SO% specific adherence to BMSCs (data not shown). Peak IL-6 secretion in culture supernatants, measured by ELISA, was observed at 24 hours (Fig 1) . IL-6 secretion by normal BMSCs in media alone was 2.1 t 0.1 ng/mL; in contrast, IL-6 secretion by ARH-77, HSS, IM-9, U266 and U937 cells in media alone was undetectable. Binding of the ARH-77 and U266 cells to BMSCs increased IL-6 secretion by 5.0 i 0.5-fold and 5.4 i 0.3-fold, respectively (n = 3, P < .05). Adherence of HS Sultan and IM-9 MM cells triggered 9.9 t-0.6-fold and 15.8 i 1 A-fold increases, respectively, in IL-6 secretion by BMSCs (n = 3, P < .OS). IL-6 secretion by BMSCs was also increased 6.2 1.8-fold by adhesion of the U937 myelomonocytic leukemic cell line, suggesting that this effect is not specific for MM cells. To define the source of MM cell adhesion-induced IL-6 secretion, BMSCs were fixed with 1% paraformaldehyde before adherence of MM cells. Although MM cell lines ARH-77, HS-Sultan, IM-9, and U-266 adhered to the fixed BMSCs, no significant increase in IL-6 secretion was noted (data not shown). These data suggest, as in our previous studies,2g that the predominant source of adhesion-related IL-6 secretion is BMSCs rather than tumor cells. BMSCs obtained from either MM patients or normal donors could not be used to characterize the molecular mechanism regulating adhesion-induced 1L-6 secretion because of their low cell numbers and low transfection efficiency. Because our previous studies" had showed that adherence of IM-9 MM cells to LP101 BMSCs resulted in increased IL-6 secretion similar to that observed after IM-9 cell adherence to BMSCs (Fig l) , we chose to use these cells as a model system for molecular studies. To assure that observed changes were not unique to LP 101 BMSCs, we also characterized IM-9 MM cell related induction of IL-6 secretion in another BMSC line, AA 101. IL-6 secretion by LP 101 and AA 101 BMSCs in media alone was 387 ? 82 pg/mL and 423 i 84 pg/mL, respectively (Fig 2A) . Adherence of MM cell lines to LP101 BMSCs for 24 hours triggered significant increases in IL-6 secretion: 2.8 2 0.3 fold for ARH-77 (n = 3, P < .M), 2.4 +-0.3-fold for HSS (n = 3, P < .Ol), 3.7 t 0.7-fold for IM-9 cells (n = 3, P < .0l), and 2.2 +-0.3-fold for U-266 cells (n = 3, P < .02). Similarly, binding of MM cell lines to AA 101 BMSCs stimulated increased 1L-6 secretion: 2.0 5 0.3-fold for ARH-77 cells (n = 3, P < .02), 2.0 t 0.2-fold for HSS cells (n = 3, P < .OS), 2.8 -C 0.7-fold for IM-9 cells, and 1.7 t 0.1 -fold for U-266 cells (n = 3, P < .04). 101 BMSCs induces IL-6 mRNA expression. Northern blotting was used to probe for 1L-6 mRNA expression during IM-9 MM cell adhesion to LP 101 and AA 101 BMSCs. Undetectable levels of IL-6 transcript were observed in either IM-9 MM cells or LP101 BMSCs cultured alone (Fig 2B) . In contrast, adherence of MM cells to BMSCs for 6 hours induced maximal 1L-6 InRNA expression (10.3 t 0.7-fold increments, as determined by densitometry); longer periods of adherence (24 hours) resulted in downregulation of these transcripts. This transient increase in IL-6 mRNA level occurred in the absence of any changes in p-actin mRNA. A similar transient induction of IL-6 mRNA expression was noted during adherence of IM-9 MM cells to AAlOl BMSCs (data not shown).
Adhesion q f l M -9 MM cells to LP101 and AA
The [L-6 promoter NF-KR site is required for M M cell adhesion-induced IL-6 gene transcription in BMSCs. To delineate MM cell adhesion-induced signalling pathways in BMSCs that induce IL-6 gene transcription, we next examined ( I ) whether MM cell adhesion to BMSCs induces the IL-6 promoter, and (2) which regulatory regions within the IL-6 promoter might be activated by adhesion.."-" Cotransfections were performed by using the luciferase construct pGL2 as an internal control,'" with each of the various pIL-6 CAT constructs. The results showed similar transfection efficiencies for the pIL-6 CAT constructs shown in Fig 3. Low to undetectable constitutive CAT activity was observed on transient transfection of LPlOl BMSCs with these constructs. CAT activity was induced by 4.8-to 6.6-fold in all promoter constructs up to position -59. Specifically. a 630-bp fragment of the IL-6 promoter. as well a s different 5' deletion mutants thereof.'s were linked to the CAT reporter gene (Fig 3) . The IL-6 promoter CAT construct (pIL-6CAT 630) was transiently transfected into LPIOI BMSCs and IM-9 MM cells were added to a confluent layer of transfected LPlOl BMSCs. The results showed an increase of 5.6 2 0.6-fold in CAT activity in cell lysates from cocultures of plL-6CAT 630 transfected LPlOl cells and IM-9 cells. compared with cell lysates from pIL-6CAT 630 transfected LPIOI cells alone ( n = 3. P < .OS). suggesting an induction of promoter activity by IM-9 cell adhesion. The 630-bp IL-6 promoter construct contains an AP-I binding site (-283 to -277): a cyclic-AMP responsive element (CRE) ( -163 to -158): NF-IL6 ( -169 to -1.35): direct repeats (-I28 to -101) : an NF-KB binding site (-73 to -63): and TATA box element (-32 to -25). Transient transfections were performed with deletion constructs of the IL-6 promoter that eliminates some of these regulatory elements. Elimination of the AP-I site. CRE. NF-IL-6, and direct repeats using pIL-6CAT22S.
plL-6CATI 38. pIL-6CATI 26. and pIL-6CATI 12 constructs. respectively, did not affect the inducibility of the IL-6 promoter (Fig 3) . These data suggested that the inducibility of IL-6 promoter activity in BMSCs in response to MM cell adhesion is not influenced by deletion of the binding site for transcription factor AP-I (-283 to -277).
which has been shown to be induced by DNA damaging agents. eg, DNA synthesis inhibitor IP-Darabinofuranosylcytosine or UV light".'"; and deletion of the binding site for the transcription factor NF-IL-6 (-169 to -135). known to be induced by IL-I ."'
In contrast. deletion of the NF-KB binding site resulted in abrogation of transcriptional activation of the IL-6 promoter in response to MM cell adhesion to BMSCs. Transient transfection of LPlOl BMSCs with the deletion plasmid pIL-6CAT72. which contains an intact NF-KB site. showed a 6.6 2 0.4-fold increase in CAT activity in response to IM-9 MM cell adhesion (n = 3. P < .OS) (Fig 3) . However. a single base pair deletion from the NF-KB binding motif in the pIL-6CAT71 plasmid. which eliminates the NF-KB site. abolished the increase in CAT activity in transfected LPlOl BMSCs on adhesion with IM-9 MM cells. These data suggest a potential role of the NF-KB element (-73 to -63) in regulating MM cell adhesion-induced IL-6 gene transcription in BMSCs.
To confirm our findings, we also used the plasmid pIL-6 CAT ~~/ N F -K B X 3, which contains three copies of synthetic NF-KB sequence (Fig 3) . The CAT assay results showed an increase of 8. To address the possibility that a portion of the MM cell adhesion-induced increases in IL-6 transcription or NF-KB activity may be in MM cells rather than BMSCs, additional experiments were performed transiently transfecting the IL-6 CAT 630 or pIL-6CAT ~~/ N F -K B X 3 constructs into IM-9 MM cells. The transfected IM-9 MM cells were adhered to LP101 BMSCs, and the cellular extracts analyzed for CAT activity. No CAT activity was observed in either MM cells transfected with IL-6 CAT constructs (pIL-6CAT 630 or pIL-6CAT ~~/ N F -K B X 3) cultured in media alone or in the cultures of transfected IM-9 MM cells adherent to LP101 BMSCs. These data suggest that BMSCs are the predominant source of IL-6 transcription and NF-KB activity in these adhesion assays.
IM-9 M M cell adhesion to AAlOl BMSCs induces IL-6
gene expression. The present findings, taken together with our and other prior studies,2y-3'.3s suggest that MM cell adhesion to either freshly isolated BMSCs, long-term BMSC cultures, or BMSC line LP101 stimulates IL-6 transcription and secretion in BMSCs. To test whether other BMSC lines are similarly responsive to adhesion of IM-9 MM cells, we determined whether adhesion of IM-9 MM cells to AAlOI, another normal human BMSC derived line, also induced IL-6 gene transcription. AA 101 cells were transiently transfected with plasmids pIL-6CAT 630, pIL-6CAT72, or pIL-6CAT7 1 (Fig 3) before IM-9 MM cell adherence, and cell lysates were analyzed for CAT activity as described above. A 4.8 2 0.4-fold increase in CAT activity in cell lysates was observed after adherence of IM-9 cells to pIL-6CAT 630 transfected AAlOl cells, compared with lysates from pIL-6CAT630 transfected AAlOl cells alone (n = 3, P < .05) (Fig 4) . Adherence of IM-9 cells to AAlOl cells that were transiently transfected with the plasmid pIL-6CAT72 (containing an intact NF-KB element but lacking binding sites for transcription factors AP-I, CRE, and NF-IL-6) resulted in a 6.1 2 0.6-fold increase in IL-6 promoter activity compared with pIL-6CAT72 transfected AAlOl cells alone (n = 3, P < .05). In contrast, IM-9 MM cell adhesion to AA 101 cells transfected with plasmid pIL-6CAT7 I , which has a single base pair deletion from the consensus NF-KB sequence, resulted in no increase in IL-6 promoter activity. These results suggested that NF-KB is potentially involved in the transcriptional activation of the 1L-6 gene in AA 101 BMSCs in response to MM cell adhesion, as was noted in LPlOl BMSCs.
IM-9 M M cell adhesion to LPlOl
BMSCs induces NF-KB binding activity. To determine whether adhesion-induced transcriptional activation of the IL-6 promoter is associated with enhanced binding of nuclear proteins to the NF-KB site, we performed EMSAs using the IL-6 NF-KB site as a probe. Nuclear extracts were prepared from LP101 cells alone, IM-9 MM cells alone, and from IM-9 MM cells adherent to LP101 BMSCs. As positive controls for the activation of NF-KB we used nuclear extracts from unstimulated and CAMPstimulated Pu5-1.8 monocytic cells, which we have previously demonstrated to contain inducible NF-KB." EMSA analysis showed only low levels of NF-KB in nuclear extracts from either IM-9 MM cells or LPlOl BMSCs cultured alone (Fig 5A) . In contrast, in nuclear extracts prepared from IM-9 MM cells adherent to LPlOl BMSCs for 1 hour (Fig 5A) a strong protein-DNA complex was formed that comigrated with CAMP-inducible NF-KB in Pu5-1.8 nuclear extracts. This protein-DNA complex appears to represent two different complexes that migrate relatively close to each other.
To gain further insight into which members of the rel/NF-KB family activated in the cocultured cells might interact with the IL-6 NF-KB site, we performed supershift assays using specific antiserum to c-Rel, p50, p65, p52, and Re1 B. The electrophoretic mobility of the complexes was decreased maximally by p50 antiserum, and to a lesser extent by p65 and c-Re1 antisera (Fig 5B) . The p52 and Re1 B antiserum did not react with complexes binding to the NF-KB site. Taken together, these results suggest that I"9 MM cell adhesion to LPlOl BMSCs induces NF-KB binding activity, and that the induced complexes binding to the NF-KB consensus site contain heterodimers of p50, p65, and c-Rel, as well as potentially homodimers of p50. In vitro evidence exists for both autocrine and paracrine mechanisms of IL-6 stimulation of MM cell line served in patients with advanced MM and plasma cell leukerr~ia,~"" coupled with transient inhibition of MM cell growth using anti-IL-6 antibodies in suggest a role for IL-6 in the pathophysiology of MM. These studies support the view that IL-6 plays a role in growth of secretory B-cell neoplasms, even though other studies find the highest serum IL-6 levels to be present in the setting of quiescent MM.60
IM-9 MM cell adhesion to
Although some MM cells secrete IL-6, the major source of IL-6 in MM is BMSCs.11"5*29-31,35 Therefore, our studies to date have specifically characterized the adhesion of MMderived cell lines to BMSCs from both normal volunteers and MM patients, and focused on determining the effect of adhesion on IL-6 secretion by BMSCs and related tumor cell pr~liferation.'~.~~ In 51chromium binding assays, the U266, ARH-77, and IM-9 MM cell lines showed specific adherence to normal and MM BMSCs. This binding of MM cells to BMSCs was partially blocked with anti-Dl integrin MoAb, anti-02 integrin MoAb, and excess RGD peptide, suggesting multiple mechanisms for adhesion of MM cell lines to BMSCs. Importantly, significant increases in IL-6 secretion were evident in MM cell line adherent normal and MM BMSC cultures; paraformaldehyde fixation of BMSCs prior to adhesion abrogated IL-6 secretion, suggesting that IL-6 secretion was triggered primarily in BMSCs rather than MM cells. These studies support the view that adhesion to BMSCs may not only localize tumor cells in marrow, but also permits cell-to-cell contact that is essential to trigger IL-6 secretion by BMSCs. Moreover, adherence of IL-6-dependent B9 cells increased their proliferation, suggesting that adherence may trigger IL-6-mediated tumor cell proliferation in a paracrine growth me~hanism.'~ The current studies extend these observations and show that MM cell line adherence to BMSC lines also triggers IL-6 secretion, as is true for MM and normal BMSCs. Moreover, they show that MM cell adhesion to BMSCs stimulates transient induction of IL-6 transcription, which precedes peak IL-6 secretion.
To understand the molecular mechanisms regulating IL-6 gene expression in BMSCs triggered by tumor cell adherence, we have begun to systematically analyze the transcriptional control mechanisms induced by adherence of MM cells to BMSCs. Although the specific ligand receptor interaction between MM cells and BMSCs triggering IL-6 remains undefined, these studies nonetheless likely reflect the interaction between tumor and BMSCs that occurs in the marrow microenvironment in vivo. We have found that induction of IL-6 secretion in BMSCs by MM cells is indeed at least partially because of an increase in the transcription rate of the IL-6 gene, suggesting the activation and/or inactivation of specific transcription factors that can bind to the regulatory regions of the IL-6 promoter. Several transcriptional control elements have been described on the IL-6 promoter: an AP-1 site, the multiple regulatory element site which contains a CRE, the NF-IL6 site, and the NF-KB Other potential regulatory elements include a glu- cocorticoid responsive element and a region highly analogous to the retinoblastoma control element.6'. 62 In the present studies we show, using promoter deletion analysis, that the NF-KB site appears to be at least one of the crucial regulatory elements for induction of the IL-6 promoter by MM cell adherence to BMSCs. This is correlated with an increase in nuclear NF-KB binding activity. Involvement of NF-KB motifs in IL-6 regulation has been extensively characterized in other cell s y s t e m~, "~~~'~~' and our future studies will be directed at defining those signaling cascades acting through NF-KB to upregulate IL-6 in BMSCs to delineate and eventually interfere with IL-6-mediated paracrine growth mechanisms in MM."~ Deletion analysis of the promoter has the disadvantage of interrupting potential cooperative interactions among different regulatory elements and, therefore, will only give partial answers. This is especially important because a cooperative interaction between NF-IL6 and NF-KB has been postulated"; for example, transcription factors NF-IL-6 and NF-KB synergistically activate transcription of the inflammatory cytokines IL-6 and IL-8.J9 We have shown in this study that adherence of MM cells to BMSCs leads to a transient activation of IL-6 gene transcription, as shown by a correlation of an increase in IL-6 mRNA with increased L 6 promoter activity. Enhanced IL-6 promoter activity appears to be associated with activation of NF-KB and is abolished on deletion of the IL-6 NF-KB site. These studies suggest that NF-KB is involved in IL-6 gene induction by MM cell adher-
